Related Experiment Video
Updated: Nov 30, 2025

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
Published on: March 15, 2016
Connective Tissue Growth Factor: From Molecular Understandings to Drug Discovery
Zihao Chen1, Ning Zhang1, Hang Yin Chu2
1School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Abstract:
Connective tissue growth factor (CTGF) is a key signaling and regulatory molecule involved in different biological processes, such as cell proliferation, angiogenesis, and wound healing, as well as multiple pathologies, such as tumor development and tissue fibrosis. Although the underlying mechanisms of CTGF remain incompletely understood, a commonly accepted theory is that the interactions between different protein domains in CTGF and other various regulatory proteins and ligands contribute to its variety of functions. Here, we highlight the structure of each domain of CTGF and its biology functions in physiological conditions. We further summarized main diseases that are deeply influenced by CTGF domains and the potential targets of these diseases. Finally, we address the advantages and disadvantages of current drugs targeting CTGF and provide the perspective for the drug discovery of the next generation of CTGF inhibitors based on aptamers.
Insights
Connective tissue growth factor (CTGF) regulates cell growth and wound healing but also contributes to diseases like fibrosis and cancer. Understanding CTGF domains offers new therapeutic targets for drug discovery.
Area of Science:
- Molecular Biology
- Biochemistry
- Pathology
Background:
- Connective tissue growth factor (CTGF) is a crucial signaling molecule.
- CTGF influences cell proliferation, angiogenesis, wound healing, tumor development, and fibrosis.
- Its diverse functions are attributed to interactions between its protein domains and other regulatory molecules.
Purpose of the Study:
- To elucidate the structure and biological functions of CTGF domains under physiological conditions.
- To summarize CTGF's role in major diseases and identify potential therapeutic targets.
- To evaluate current CTGF-targeting drugs and propose future aptamer-based inhibitor strategies.
Main Methods:
- Structural analysis of CTGF domains.
- Review of literature on CTGF's role in physiological and pathological processes.
- Analysis of existing CTGF-targeting drugs and aptamer technology.
Main Results:
- Detailed description of CTGF domain structures and their functions.
- Identification of key diseases influenced by CTGF, including cancer and fibrosis.
- Assessment of current drug limitations and potential of aptamer-based inhibitors.
Conclusions:
- CTGF domain structure and interactions are central to its multifaceted roles.
- Targeting CTGF offers therapeutic potential for various diseases.
- Aptamer-based inhibitors represent a promising avenue for next-generation CTGF-targeted therapies.
More Related Videos
09:56Tension Gauge Tether Probes for Quantifying Growth Factor Mediated Integrin Mechanics and Adhesion
Published on: February 11, 2022
09:34Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair
Published on: September 7, 2017
Related Concept Videos
TGF - β Signaling Pathway
Drug Discovery: Overview
Tissue-Drug Binding: Localization of Drugs and its Significance
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Mitogens and the Cell Cycle
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...